These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 3866801

  • 1. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 2. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E, Murae M, Koga R, Odawara Y, Nakabayashi Y, Yokoyama K, Nakata H, Totake T, Ochiai K, Yasuda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [Abstract] [Full Text] [Related]

  • 4. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of CA125 as a circulating tumor marker for ovarian cancer.
    Kuzuya K, Nozaki M, Chihara T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):949-57. PubMed ID: 3461071
    [Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
    Iwasaka T, Ohkuma Y, Yoshimura T, Sugimori H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

  • 9. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K, Yasui Y, Asai H, Hisaoka T, Mizuno K, Yagami Y.
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G.
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [Abstract] [Full Text] [Related]

  • 14. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR, Wang EY, Wang XX, Jia XH, Li L.
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [Abstract] [Full Text] [Related]

  • 15. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M, Ogawa H, Nakanishi K, Tanizawa O, Karino K, Endo J.
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [Abstract] [Full Text] [Related]

  • 16. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
    Liu W.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
    [Abstract] [Full Text] [Related]

  • 17. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC.
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [Abstract] [Full Text] [Related]

  • 18. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
    Kawai M, Yamashita H, Hayashi T, Kamiya N, Kakihara M, Arii Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):402-10. PubMed ID: 3457877
    [Abstract] [Full Text] [Related]

  • 19. Preoperative tumor marker CA125 levels in relation to epithelial ovarian cancer stage.
    Fures R, Buković D, Hodek B, Klarić B, Herman R, Grubisić G.
    Coll Antropol; 1999 Jun; 23(1):189-94. PubMed ID: 10402722
    [Abstract] [Full Text] [Related]

  • 20. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S, Aoki D, Yajima M, Tsukazaki K, Kobayashi T, Kimura E, Terashima Y, Inaba N, Takamizawa H, Negishi Y.
    Cancer Res; 1992 Mar 01; 52(5):1205-9. PubMed ID: 1737381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.